• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他莫昔芬对口腔细菌的新用途

Repurposing of Tamoxifen Against the Oral Bacteria.

作者信息

Al-Janabi Ali Abdul Hussein S

机构信息

Karbala University College of Medicine, Department of Microbiology, Karbala, Iraq.

出版信息

Turk J Pharm Sci. 2021 Feb 25;18(1):68-74. doi: 10.4274/tjps.galenos.2019.23500.

DOI:10.4274/tjps.galenos.2019.23500
PMID:33634670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7957305/
Abstract

OBJECTIVES

Tamoxifen (TAM), which is used for treating breast cancer, has exhibited another important function as an antimicrobial agent. The objective of this study is to investigate the antibacterial action of TAM against the bacteria present in the human oral cavity.

MATERIALS AND METHODS

The bacteria present in the human oral cavity were isolated from healthy individuals. Different concentrations of TAM were tested against the isolated bacteria. Additionally, bactericidal and bacteriostatic effects of TAM were also determined.

RESULTS

Out of 23 isolated bacteria, a greater number of Gram-positive bacteria were highly susceptible to the low concentrations of TAM than Gram-negative bacteria. , which is Gram-positive bacterium, and , which is Gram-negative bacterium, needed a high minimum inhibitory concentration value of TAM (2.5 mg/mL) to be inhibited by TAM's bacteriostatic action. Resistance to TAM was also observed in three strains of Gram-positive and four strains of Gram-negative bacteria.

CONCLUSION

TAM has shown a potential antibacterial effect against the bacteria present in the oral cavity, especially against Gram-positive bacteria. This effect is mostly bacteriostatic. This study also found bacterial resistance toward TAM.

摘要

目的

用于治疗乳腺癌的他莫昔芬(TAM)已展现出作为抗菌剂的另一重要功能。本研究的目的是调查TAM对存在于人体口腔中的细菌的抗菌作用。

材料与方法

从健康个体中分离出存在于人体口腔中的细菌。针对分离出的细菌测试不同浓度的TAM。此外,还确定了TAM的杀菌和抑菌作用。

结果

在23株分离出的细菌中,相较于革兰氏阴性菌,更多的革兰氏阳性菌对低浓度的TAM高度敏感。革兰氏阳性菌金黄色葡萄球菌和革兰氏阴性菌牙龈卟啉单胞菌需要较高的TAM最小抑菌浓度值(2.5毫克/毫升)才能被TAM的抑菌作用抑制。在三株革兰氏阳性菌和四株革兰氏阴性菌中也观察到了对TAM的耐药性。

结论

TAM已显示出对口腔中存在的细菌具有潜在的抗菌作用,尤其是对革兰氏阳性菌。这种作用主要是抑菌作用。本研究还发现了细菌对TAM的耐药性。

相似文献

1
Repurposing of Tamoxifen Against the Oral Bacteria.他莫昔芬对口腔细菌的新用途
Turk J Pharm Sci. 2021 Feb 25;18(1):68-74. doi: 10.4274/tjps.galenos.2019.23500.
2
Molecular and pharmacokinetic evaluation of rat hepatic and gastrointestinal cytochrome p450 induction by tamoxifen.
Pharmacology. 2001;63(4):210-9. doi: 10.1159/000056136.
3
Regulation of Lipid Membrane Partitioning of Tamoxifen by Ionic Strength and Cholesterol.离子强度和胆固醇对他莫昔芬在脂膜中分配的调节。
Pharm Res. 2020 Feb 10;37(3):53. doi: 10.1007/s11095-020-2771-8.
4
Tamoxifen sensitivity-testing of glioblastomas: comparison of in vitro and in vivo results.
Acta Neurochir (Wien). 2001;143(6):563-73. doi: 10.1007/s007010170061.
5
Pomegranate sensitizes Tamoxifen action in ER-α positive breast cancer cells.石榴使 ER-α 阳性乳腺癌细胞对他莫昔芬敏感。
J Cell Commun Signal. 2011 Dec;5(4):317-24. doi: 10.1007/s12079-011-0138-y. Epub 2011 Jun 27.
6
Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.他莫昔芬代谢物的再利用治疗耐甲氧西林金黄色葡萄球菌和万古霉素耐药粪肠球菌感染。
Microbiol Spectr. 2021 Oct 31;9(2):e0040321. doi: 10.1128/Spectrum.00403-21. Epub 2021 Oct 20.
7
Synergistic antimicrobial activity of combinations of sanguinarine and EDTA with vancomycin against multidrug resistant bacteria.血根碱与乙二胺四乙酸(EDTA)联合万古霉素对多重耐药菌的协同抗菌活性。
Drug Metab Lett. 2014;8(2):119-28. doi: 10.2174/187231280802150212100742.
8
Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance.在获得性他莫昔芬耐药的人乳腺肿瘤中,激活蛋白-1 DNA结合增加及c-Jun氨基末端激酶活性增强。
Clin Cancer Res. 1999 Feb;5(2):251-6.
9
Cyathea gigantea (Cyatheaceae) as an antimicrobial agent against multidrug resistant organisms.巨鳞铁角蕨(铁角蕨科)作为一种抗多重耐药菌的抗菌剂。
BMC Complement Altern Med. 2019 Oct 22;19(1):279. doi: 10.1186/s12906-019-2696-0.
10
Bacteriostatic and Bactericidal Activity of Deer Musk on Multidrug Resistance Bacteria.麝香对多重耐药菌的抑菌和杀菌活性
Pak J Biol Sci. 2018 Jan;21(7):331-339. doi: 10.3923/pjbs.2018.331.339.

引用本文的文献

1
Tooth loss in breast cancer patients: A comparison between tamoxifen-treated and non-treated patients.乳腺癌患者的牙齿缺失:他莫昔芬治疗与未治疗患者的比较。
Med Oral Patol Oral Cir Bucal. 2024 Jul 1;29(4):e552-e558. doi: 10.4317/medoral.26528.
2
Efficacy of Tamoxifen Metabolites in Combination with Colistin and Tigecycline in Experimental Murine Models of and .他莫昔芬代谢物与黏菌素和替加环素联合在实验性小鼠模型中的疗效。 (你提供的原文中后面两个“and”后缺少具体内容,所以翻译可能不太完整准确,你可补充完整后再让我翻译。)
Antibiotics (Basel). 2024 Apr 24;13(5):386. doi: 10.3390/antibiotics13050386.
3
Exploring Darunavir, Rilpivirine and Etravirine as Potential Therapies for Bladder Cancer: Efficacy and Synergistic Effects.探索达芦那韦、利匹韦林和依曲韦林作为膀胱癌潜在治疗方法的疗效及协同作用
Biomedicines. 2024 Mar 14;12(3):647. doi: 10.3390/biomedicines12030647.
4
Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel Polymyxin/Non-Antibiotic Combinations.对抗多重耐药革兰氏阴性病原菌的药物重新利用方法:新型多粘菌素/非抗生素组合
Pathogens. 2022 Nov 25;11(12):1420. doi: 10.3390/pathogens11121420.

本文引用的文献

1
In vitro antimicrobial activity against Abiotrophia defectiva and Granulicatella elegans biofilms.对缺陷拟杆菌和优雅颗粒菌生物膜的体外抗菌活性。
J Antimicrob Chemother. 2019 Aug 1;74(8):2261-2268. doi: 10.1093/jac/dkz174.
2
A 5-year surveillance on antimicrobial resistance of isolates at a level-I trauma centre of India.印度一家一级创伤中心分离株抗菌药物耐药性的5年监测。
J Lab Physicians. 2019 Jan-Mar;11(1):34-38. doi: 10.4103/JLP.JLP_72_18.
3
Multidrug-Resistant Complex Emerging as a Global, Diversifying Threat.多重耐药复合体正成为一种全球性、不断多样化的威胁。
Front Microbiol. 2019 Jan 31;10:44. doi: 10.3389/fmicb.2019.00044. eCollection 2019.
4
Drug Repurposing for the Treatment of Bacterial and Fungal Infections.药物重新利用用于治疗细菌和真菌感染。
Front Microbiol. 2019 Jan 28;10:41. doi: 10.3389/fmicb.2019.00041. eCollection 2019.
5
Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease.重新利用雌激素受体拮抗剂治疗传染病。
mBio. 2018 Dec 18;9(6):e02272-18. doi: 10.1128/mBio.02272-18.
6
Mechanistic Insights From Global Metabolomics Studies into Synergistic Bactericidal Effect of a Polymyxin B Combination With Tamoxifen Against Cystic Fibrosis MDR .全球代谢组学研究对多粘菌素B与他莫昔芬联合用药对囊性纤维化多重耐药菌的协同杀菌作用的机制性见解
Comput Struct Biotechnol J. 2018 Nov 10;16:587-599. doi: 10.1016/j.csbj.2018.11.001. eCollection 2018.
7
Antimicrobial Susceptibilities of Oral Isolates of and According to the Consensus Guidelines for Fastidious Bacteria.根据苛养菌共识指南对[具体细菌名称]口腔分离株的抗菌药敏情况 。 你原文中“ and ”之间应该有具体的细菌名称,请补充完整以便更准确翻译。
Medicines (Basel). 2018 Dec 3;5(4):129. doi: 10.3390/medicines5040129.
8
Clinical presentations, management outcomes, and diagnostic dilemma in Kocuria endophthalmitis.科氏葡萄球菌性眼内炎的临床表现、治疗结果及诊断困境
J Ophthalmic Inflamm Infect. 2018 Nov 20;8(1):21. doi: 10.1186/s12348-018-0163-6.
9
Virulence Factors and Antibiotic Resistance of Strains Isolated From Neonates With Sepsis.从新生儿败血症分离菌株的毒力因子和抗生素耐药性
Front Med (Lausanne). 2018 Aug 14;5:225. doi: 10.3389/fmed.2018.00225. eCollection 2018.
10
Antimicrobial Resistance in .抗菌药物耐药性在. 中
Microbiol Spectr. 2018 Jul;6(4). doi: 10.1128/microbiolspec.ARBA-0026-2017.